These outcomes, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two assist the concept of targeting ACKR3 as a novel strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-related disorders.Disclaimer: The above mentioned is act